Effects of licorice root supplementation on liver enzymes, hepatic steatosis, metabolic and oxidative stress parameters in women with nonalcoholic fatty liver disease: A randomized double-blind clinical trial
- PMID: 35785498
- DOI: 10.1002/ptr.7543
Effects of licorice root supplementation on liver enzymes, hepatic steatosis, metabolic and oxidative stress parameters in women with nonalcoholic fatty liver disease: A randomized double-blind clinical trial
Abstract
This study aimed to evaluate the effects of licorice root supplementation on liver enzymes, hepatic steatosis, metabolic and oxidative stress parameters in women with nonalcoholic fatty liver disease (NAFLD). In this randomized double-blind, placebo-controlled trial, 60 women with NAFLD were selected and randomly assigned into 2 groups to take 1,000 mg/day powder of licorice root extract or placebo for 12 weeks. In addition, all the patients were advised to follow a weight loss diet and healthy lifestyle. The plasma levels of liver enzymes, glycemic indices, lipid profile, oxidative stress parameters, as well as hepatic steatosis were measured at the beginning and end of the study. Through the 12-weeks period of supplementation, women who received powder of licorice root experienced a statistically significant improvement in alanine aminotransferase (p < .001), insulin (p = .002), insulin resistance (p = .003), malondialdehyde (p < .001) serum levels, and ultrasonographic findings of liver steatosis (p < .001), compared to the placebo group. In conclusion, licorice root supplementation in addition to gradual weight loss and lifestyle modification is superior to lifestyle modification alone for the treatment of NAFLD.
Keywords: herbal medicine; licorice; liver enzymes; nonalcoholic fatty liver disease.
© 2022 John Wiley & Sons Ltd.
Similar articles
-
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.Nutr Res. 2014 Oct;34(10):837-43. doi: 10.1016/j.nutres.2014.09.005. Epub 2014 Sep 23. Nutr Res. 2014. PMID: 25311610 Clinical Trial.
-
The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial.Complement Ther Med. 2018 Dec;41:118-123. doi: 10.1016/j.ctim.2018.09.010. Epub 2018 Sep 17. Complement Ther Med. 2018. PMID: 30477827 Clinical Trial.
-
The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.Br J Nutr. 2015 Sep 14;114(5):796-803. doi: 10.1017/S0007114515002433. Epub 2015 Aug 3. Br J Nutr. 2015. PMID: 26234526 Clinical Trial.
-
Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial.Br J Nutr. 2020 Aug 28;124(4):450-456. doi: 10.1017/S0007114520001403. Epub 2020 Apr 21. Br J Nutr. 2020. PMID: 32312333 Clinical Trial.
-
A narrative review on the role of hesperidin on metabolic parameters, liver enzymes, and inflammatory markers in nonalcoholic fatty liver disease.Food Sci Nutr. 2023 Oct 8;11(12):7523-7533. doi: 10.1002/fsn3.3729. eCollection 2023 Dec. Food Sci Nutr. 2023. PMID: 38107097 Free PMC article. Review.
Cited by
-
Innovative treatments for obesity and NAFLD: A bibliometric study on antioxidants, herbs, phytochemicals, and natural compounds.Heliyon. 2024 Aug 8;10(16):e35498. doi: 10.1016/j.heliyon.2024.e35498. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39220898 Free PMC article. Review.
-
Effects of licorice extract in combination with a low-calorie diet on obesity indices, glycemic indices, and lipid profiles in overweight/obese women with polycystic ovary syndrome (PCOS): a randomized, double-blind, placebo-controlled trial.J Ovarian Res. 2024 Jul 30;17(1):157. doi: 10.1186/s13048-024-01446-9. J Ovarian Res. 2024. PMID: 39080737 Free PMC article. Clinical Trial.
-
The additive effect of herbal medicines on lifestyle modification in the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis.Front Pharmacol. 2024 Feb 23;15:1362391. doi: 10.3389/fphar.2024.1362391. eCollection 2024. Front Pharmacol. 2024. PMID: 38464716 Free PMC article.
-
Licorice extract inhibits the cGAS-STING pathway and protects against non-alcoholic steatohepatitis.Front Pharmacol. 2023 Apr 4;14:1160445. doi: 10.3389/fphar.2023.1160445. eCollection 2023. Front Pharmacol. 2023. PMID: 37081966 Free PMC article.
-
Pharmacological effects of Chinese medicine modulating NLRP3 inflammasomes in fatty liver treatment.Front Pharmacol. 2022 Sep 8;13:967594. doi: 10.3389/fphar.2022.967594. eCollection 2022. Front Pharmacol. 2022. PMID: 36160411 Free PMC article. Review.
References
REFERENCES
-
- Adams, L. A., Sanderson, S., Lindor, K. D., & Angulo, P. (2005). The histological course of nonalcoholic fatty liver disease: A longitudinal study of 103 patients with sequential liver biopsies. Journal of Hepatology, 42, 132-138.
-
- Bell, Z. W., Canale, R. E., & Bloomer, R. J. (2011). A dual investigation of the effect of dietary supplementation with licorice flavonoid oil on anthropometric and biochemical markers of health and adiposity. Lipids in Health and Disease, 10, 1-10.
-
- Chiva-Blanch, G., & Badimon, L. (2017). Effects of polyphenol intake on metabolic syndrome: Current evidences from human trials. Oxidative Medicine and Cellular Longevity, 2017, 1-18.
-
- Day, C. & James, O. Steatohepatitis: a tale of two “hits” Gastroenterology. 1998; 114 (4): 842-845. 10.s0016-5085
-
- Elicoh-Middleton, J., Chithan, K., & Theoharis, C. (2010). Effect of plant flavonoids on mammalian cells: Implications for inflammation, heart diseases and cancer. Pharmacology and Experimental Therapeutics, 4, 673-751.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
